418 results on '"Vandenbroeck, Koen"'
Search Results
2. Inflammation in human carotid atheroma plaques
3. Expression regulation and comparative interactome study of ANKRD55, a multiple sclerosis risk modulator
4. Esklerosi anizkoitzaren IL22RA suszeptibilitate-genearen analisia
5. Characterization of the Isoforms of the Multiple Sclerosis Risk Protein, IL-22 Binding Protein (IL-22BP)
6. Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55-IL6ST Gene Region in Immature Dendritic Cells
7. Pathophysiology of Atherosclerosis
8. Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55-IL6ST Gene Region in Immature Dendritic Cells
9. Pathophysiology of Atherosclerosis
10. Boosting Cholesterol Efflux from Foam Cells by Sequential Administration of rHDL to Deliver MicroRNA and to Remove Cholesterol in a Triple‐Cell 2D Atherosclerosis Model
11. Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55–IL6ST Gene Region in Immature Dendritic Cells
12. Genome-wide significant association with seven novel multiple sclerosis risk loci
13. Characterization of IL22RA2, a risk locus for multiple sclerosis: ID: 182
14. Role of cyclophilins B & C in the assembly of IL-12 and IL-23 in the endoplasmic reticulum: ID: 164
15. IL23A (p19) expression and subcellular location in cancer cell lines under endoplasmic reticulum stress conditions: ID: 152
16. Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain
17. A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis
18. Nanopartikulen lipido konposizioak rHDLen kolesterol kanpora-fluxuaren efizientzian eragina du
19. Novel Transcript Discovery Expands the Repertoire of Pathologically-Associated, Long Non-Coding RNAs in Vascular Smooth Muscle Cells
20. Characterization of the Isoforms of the Multiple Sclerosis Risk Protein, IL-22 Binding Protein (IL-22BP)
21. Pharmacogenomics and Multiple Sclerosis: Moving Toward Individualized Medicine
22. Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis.
23. Novel Transcript Discovery Expands the Repertoire of Pathologically-Associated, Long Non-Coding RNAs in Vascular Smooth Muscle Cells
24. BIRC6 Is Associated with Vulnerability of Carotid Atherosclerotic Plaque
25. Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition
26. The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis
27. Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition
28. A new risk variant for multiple sclerosis at 11q23.3 locus is associated with expansion of CXCR5+ circulating regulatory T cells
29. Pharmacogenomics of Type I interferon therapy: A survey of response-modifying genes
30. ITGA4 polymorphisms and susceptibility to multiple sclerosis
31. The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP( ADCYAP1), and susceptibility to multiple sclerosis
32. BIRC6 Is Associated with Vulnerability of Carotid Atherosclerotic Plaque
33. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis
34. Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk
35. Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis
36. Primitive endothelial cell lines from the porcine embryonic yolk sac
37. Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy?
38. Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients
39. Multi-chaperone complexes regulate the folding of interferon-γ in the endoplasmic reticulum
40. Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects
41. Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients
42. The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery?
43. Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition
44. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
45. A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells
46. The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis
47. IFN-β pharmacogenomics in multiple sclerosis
48. The IFNG–IL26–IL22 Cytokine Gene Cluster
49. Genetic polymorphisms, their allele combinations and IFN-β treatment response in Irish multiple sclerosis patients
50. United Europeans for development of pharmacogenomics in multiple sclerosis network
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.